Start Date
November 25, 2022
Primary Completion Date
March 30, 2023
Study Completion Date
March 30, 2023
BAR502
"Single oral doses of BAR 502/placebo will be administered as film-coated tablets, in the morning of Day 1, with 240 mL of water, after an overnight fasting of at least 8 hours.~BAR 502 film-coated tablets are available at dose strengths of 10, 50 and 150 mg. A maximum of 4 dose levels are pre-planned (10 mg, 50 mg, 150 mg, 300 mg)."
Placebo
Matching BAR 502 placebo film-coated tablets will be given to 2 out of 8 subjects in each cohort using the same regimen as outlined for the active study treatment
BlueClinical Phase I, Porto
Lead Sponsor
BAR Pharmaceuticals s.r.l.
NETWORK